Statin therapy is associated with lower mortality among patients with severe heart failure

被引:187
作者
Mozaffarian, D
Nye, R
Levy, WC
机构
[1] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[5] Pfizer PGRD, New London, CT USA
[6] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA
关键词
D O I
10.1016/j.amjcard.2004.01.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Experimental considerations suggest both potential harm and benefit from statin therapy in patients with severe heart failure. However, relations of statin therapy with clinical outcomes in severe heart failure are not well established. Using data from the Prospective Randomized Amlodipine Survival Evaluation (PRAISE) trial, we evaluated associations of statin therapy with total mortality among 1,153 patients with severe heart failure (ejection fraction <30% and New York Heart Association class IIIB or IV symptoms) of ischemic and nonischemic etiologies. Statin therapy was administered to 134 patients (12%) during the study period. Over a 1.3-year mean follow-up, there were 413 deaths (29 deaths/100 person-years). Adjusting for age, gender, diabetes, smoking, heart failure etiology, ejection fraction, and New York Heart Association class, statin therapy was associated with a 62% lower risk of death (hazard ratio 0.38, 95% confidence interval 0.23 to 0.65), or 1 fewer death/5 patients taking statin therapy for 1 year. This association was not greatly altered by additional adjustment for a variety of other patient characteristics, including serum cholesterol levels. After propensity score analyses, statin therapy was still associated with a 48% lower risk of death (hazard ratio 0.52, 95% confidence interval 0.30 to 0.89). Although this observational study does not prove causality, further investigation of potential benefits of statins in patients with severe heart failure appears warranted. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:1124 / 1129
页数:6
相关论文
共 25 条
  • [1] *AM HEART ASS, 2001, 2002 HEART STROK STA
  • [2] Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction
    Bauersachs, J
    Galuppo, P
    Fraccarollo, D
    Christ, M
    Ertl, G
    [J]. CIRCULATION, 2001, 104 (09) : 982 - 985
  • [3] Pathophysiological, role of cytokines in congestive heart failure
    Blum, A
    Miller, H
    [J]. ANNUAL REVIEW OF MEDICINE, 2001, 52 : 15 - 27
  • [4] Lipid-lowering drugs and mitochondrial function: Effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio
    DePinieux, G
    Chariot, P
    AmmiSaid, M
    Louarn, F
    Lejonc, JL
    Astier, A
    Jacotot, B
    Gherardi, R
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (03) : 333 - 337
  • [5] Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction
    Hayashidani, S
    Tsutsui, H
    Shiomi, T
    Suematsu, N
    Kinugawa, S
    Ide, T
    Wen, J
    Takeshita, A
    [J]. CIRCULATION, 2002, 105 (07) : 868 - 873
  • [6] *HLTH CAR FIN ADM, HEART FAIL NAT PROJ
  • [7] Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
    Holm, T
    Andreassen, AK
    Ueland, T
    Kjekshus, J
    Froland, SS
    Kjekshus, E
    Simonsen, S
    Aukrust, P
    Gullestad, L
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06) : 815 - +
  • [8] Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure
    Horwich, TB
    Hamilton, MA
    MacLellan, WR
    Fonarow, GC
    [J]. JOURNAL OF CARDIAC FAILURE, 2002, 8 (04) : 216 - 224
  • [9] Comparative dose efficacy study of Atorvastatin versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in patients with hypercholesterolemia (The CURVES study)
    Jones, P
    Kafonek, S
    Laurora, I
    Hunninghake, D
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (05) : 582 - 587
  • [10] Kapadia Samir, 1998, Cardiology Clinics, V16, P645, DOI 10.1016/S0733-8651(05)70041-2